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Abstract 
The biological effects of both spinosad (4.7%) and flubex (diflubenzuron DT 2%) against Aedes 
aegypti (Ae. aegypti (L.) mosquito larvae were assessed under laboratory conditions. The LC50 
values of the spinosad and diflubenzuron were 0.22 ppm and 0.0019 ppm respectively, against 
Ae. aegypti larvae. The mortality rate of mosquito larvae ranged from 35- 96 % and 2-20 % for 
those spinosad and diflubenzuron separately. The results revealed that the spinosad 
formulation was highly effective against larvae comparing with flubex. Larval treatment with the 
IGR diflubenzuron reduced the reproductive potential of adult mosquito that emerged from 
these treatments by 16-84%. These results revealed that although flubex is an IGR, its 
larvicidal activity is better than spinosad. Further assessments and field investigation on IGRs 
products as insecticides alternatives should be carried out for managing Ae. aegypti 
mosquitoes. 
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INTRODUCTION 
Mosquitoes are the most medically important insect 
species due to their capacity in carrying and transmitting 
both animal and human diseases (Ikhlak et al., 2016; Snow 
et al., 1999; Roth et al., 2010; Weaver et al., 2010). Aedes 
aegypti (L.) is widely spread throughout the world, including 
tropical and subtropical areas and it is recognized as the 
most important vector for transmitting serious diseases 
such as dengue, chikungunya and Zika viruses (Benelli, 
2016 a,b) 
In Saudi Arabia, the first dengue outbreak in over 50 
years, was in Jeddah city in 1994 (Gubler, 2002). Since 
that time, dengue fever has emerged as a major public 
health problem in Jeddah city (WHO 2010) and dengue 
virus surveillance was established after that time (Fakeeh 
and Zaki, 2001). In 2006, dengue fever reported cases had 
risen drastically compared to the earlier recorded numbers 
(Aburas, 2007).  
Due to extensive use of chemical insecticides for 
several decades to manage mosquitoes populations 
(Hemingway and Ranson, 2000), mosquitoes have 
developed resistance to these insecticides. Furthermore, 
health concerns have promoted research to find alternative 
insecticides for effective control of vector mosquitoes 
(Uragayala et al., 2015). The key criteria for an effective 
mosquito larvicide  is low mammalian toxicity, low impact 
on the environment, the  broad spectrum of activity against 
all target species of mosquito and a long duration of effect 
that  reducing  application frequency. The researchers 
started to look for new insecticides having new modes of 
action to either prevent or reduce the impact of insecticide 
resistance to the previous generation of insecticides 
(Darriet and Corbel, 2006; Perez et al., 2007 and WHO, 
2012). Insect growth regulators (IGRs) appeared as 
alternatives to such chemical larvicides due to their low 
mammalian toxicity, biologically specific and 
environmentally safe and have been recommended for Ae. 
aegypti control (Thavara et al., 2004;Silva et al., 2009). 
Spinosad DT is a naturally derived insecticide 
composed of a mixture of two metabolites (spinosins A and 
D) obtained by fermentation process employing the soil 
bacterium Saccharopolyspora spinosad (Actinomycetales). 
It is highly virulent by both contact and ingestion to several 
dipterous insect pests (Bacci L et al., 2016; Prabhu et al., 
2011). Due to its lower mammalian toxicity and its 
environmental impact, lower persistence and lower toxicity 
to a number of predaceous insects, it has been approved to 
control mosquito larvae in drinking water (Tomlin, 2000; 
Williams et al., 2003; WHO, 2010). Three formulations 
(granules, aqueous suspension concentrate and tablets) of 
spinosad have been evaluated by WHO (2007) for 
mosquito larvae control. It has been used as a larvicide at 
0.25–0.5 mg/l active ingredient for controlling Ae. aegypti in 
drinking-water containers. Technical and formulated 
spinosad has been evaluated against larvae of several 
important mosquito species under laboratory conditions. 
Both LC50 and LC90 technical material of the Spinosad 
against Ae. aegypti larvae ranged from 0.155 to 0.35 mg/L 
AI and 0.185 to 0.92 mg/L AI respectively (WHO ,2007). 
Another study was conducted against Ae. aegypti, 
Anopheles gambiae, and Cx. quinquefasciatus larvae with 
technical material dissolved in ethanol (Darriet et al., 2005). 
Spinosad was found to be more active against larvae of An. 
gambiae, followed by Cx. quinquefasciatus and Ae. 
aegypti. The LC50 and LC90 values were: 0.01–0.032 mg/L 
AI (An. gambiae), 0.093–0.49 mg/L AI (Cx. 
quinquefasciatus) and 0.35– 0.92 mg/L AI (Ae. aegypti) 
respectively. A couple of formulations of spinosad, direct 
application tablet (DT) and 0.5% granules (GR), at 3 
dosages (0.25, 0.5 and 1.0 mg/l) were evaluated against 
Ae. aegypti larvae (Thavara et al., 2009). A percentage of 
79-100 IE for 34 days was produced by The DT formulation 
at the highest concentration (1.0 mg/l) whilst after 62 days 
90-100% IE was obtained. These results indicate a longer 
residual period of such formulation. 
Flubex (Diflubenzuron 2%) is another GR mainly works 
through ingestion leading to inhibition of both synthesis and 
deposition of the chitin in the body wall of the treated 
immature stages of the insects that finally causing death 
(Sihuincha et al., 2005). The Cuticle of treated larvae is 
unable to withstand increased pressure during the ecdysis 
process and fail to provide adequate muscular support 
during molting. Such larvae are unable to throw their 
exuviae and finally die due to either starvation or rupture of 
the new, delicate, malformed cuticle. According to 
WHOPES recommendation (WHO, 2006), Diflubenzuron 
wettable powder has been used in mosquito larvae control 
since the mid-1970’s.  
Several studies have evaluated  insect growth 
regulators (IGRs) for mosquito control in different regions of 
the world (Mulla et al., 2003; Cetin et al., 2006 ;Silva et al., 
2009 Jacups et al., 2014; Anjum, et al., 2017). In the 
present investigation, two nonconventional insecticides, 
diflubenzuron 2% DT and spinosad 7.48% DT, were used 
to control Ae. aegypti larvae based on recommendations 
made by WHO (2007,2009) for controlling the mosquito 
larvae. 
  
MATERIALS AND METHODS 
Mosquito Rearing 
The mosquito Ae.aegypti (L.) was chosen an 
experimental insect for the present study, because it is 
considered as one of the most important biting and 
nuisance mosquitoes and the major vector for dengue 
fever in the study area. Larvae were obtained from the 
Municipality of Jeddah and were reared to produce a 
colony under laboratory conditions. The colony was 
maintained in insectary at room temperature (27± l °C), 
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relative humidity of 70±5% and 14:10 (L: D) controlled 
photoperiod. Larvae were fed on fish food and males were 
fed on 10% glucose sugars whilst females get their blood 
meals from domestic pigeons. 
 
Insecticides  
Two commercial formulations of IGRS, flubex and 
spinosad, were used in larval bioassays. Flubex 
(diflubenzuron 2% DT) was obtained from Agricultural 
office-Jeddah, Saudi-Arabia and spinosad (7.48% DT.) was 
obtained from the Municipality of Jeddah. These 
insecticides were selected for larval bioassay due to their 
usage as larvicides to control the container - breeding Ae. 
aegypti in vector control programs in Jeddah city, Saudi 
Arabia. 
 
Larval bioassays  
       Bioassays were undertaken according to 
instructions of WHO (1981). A stock solution of both 
spinosad and diflubenzuron were obtained by grinding and 
dissolving the tablets in a suitable solvent. A stock solution 
of spinosad and diflubenzuron were prepared by dilution 
with distilled water and homogenized by shaking until 
completely dissolved, required concentrations were diluted 
immediately prior to use in bioassays. 
The late third or early emerged fourth instar larvae of 
Ae.aegypti were selected for use in bioassays. Larvae were 
subjected to series of concentrations from Spinosad 7.48% 
DT (0.125-2 ppm) and flubex 2% (0.0004-0.008 ppm). 
Twenty five larvae were placed in 249 ml of de-chlorinated 
tap-water plus 1ml from the concentration of the insecticide 
in pyrex beakers. Each concentration has four replicates 
and control. Mortality was monitored at 24 hours intervals 
after initial exposure. Larvae that showed lack of movement 
in response to continued probing were considered dead. 
Larval and pupal mortalities were recorded daily whilst alive 
pupae were transferred to untreated water in new beakers 
and left until the emergence of the last mosquito. Both 
partially emerged mosquitoes and those found completely 
emerged but unable to leave the water surface were 
recorded and considered as dead adults. 
 
Statistical analysis 
Results of bioassays were corrected by using Abbott's 
formula (Abbott, 1925) when control mortality exceeded 
10% which never happened then subjected to probit 
analysis (Finney, 1952). Probit regression analysis 
programme was used to analyze mortality data to obtain 
LC50  and LC95 of tested compounds. Statistical differences 
between LC50 values were determined based on 
overlapping of 95% confidence intervals. The chi-square 
test was used to calculate the respective slope lines. 
 
RESULTS AND DISCUSSION 
Two non-conventional insecticides (IGR) flubex 2% DT 
and spinosad 7.48% DT were evaluated against Ae.aegypti 
larvae. The cumulative mortalities of the development 
stage have been considered as a criterion for the 
evaluation of the IGRS due to their delayed action against 
such stages (WHO, 2005a). Larval and pupal mortality 
percentages as well as inhibition of adult emergence were 
shown in tables (1, 2) and figure (1). 
As shown in the table (2) the mortalities of larvae 
treated with effective concentrations of diflubenzuron 
compound were very low and ranged from 2 to 20%. These 
results could be due to either the delayed or the cumulative 
effects of this compound on the developmental stages of 
mosquitoes. These results are in agreement with 
Georghiou and Lin (1974) who mentioned that we should 
not use larval mortality as indicator when we evaluating 
effects of these compounds against mosquito larvae due to 
their delayed or cumulative effects on mosquitoes 
developmental stages. Therefore IC50 (Concentration that 
inhibits the emergence of 50% of mosquito) was used as 
the criterion rather than LC50 (Concentration that kills 50% 
of mosquito larvae) in the present work. In contrary, 
spinosad was highly effective against the Ae.aegypti larvae 
and showed 35- 96 % mortality (Table 1), whereas the 
corresponding percentages of adult emergence inhibition 
were 16-84% for diflubenzuron. The IC50 and IC90 that 
prevented adults emergence from larvae treated with 
diflubenzuron were 0.0019 and 0.0022 ppm respectively. 
Results revealed that the spinosad formulation was 
highly effective against larvae (Table 1) with LC50 = 0.22 
ppm. However, diflubenzuron was more effective in 
inhabiting adult emergence. The present study indicated 
that diflubenzuron showed a significant effect in inhibiting 
adult emergence with higher mortality in the pupal stage 
(84%) and lower mortality in the larval stage (20%). 
Contrarily, Spinosad revealed high  mortality percentage  of 
larvae (96%) compared with diflubenzuron. Furthermore, 
pupal mortality and incomplete adult emergence were 
recorded.  
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Table 1. Larvicidal effects and statistical parameters of spinosad on Ae. aegypti. 
 
 
Table 2. Biological effects and statistical parameters of IGR diflubenzuron 2% on developmental stages of Ae. 
aegypti. 
Con.(ppm) Larval Mortality 
(%)
A
 
Pupa 
Produced 
Adult% Statistical 
parameters 
Adult
 
Stage 
Emergence Inhibition (%)
B
 
0.0004 2 94 84 16 LC50 (ppm) 0.0019 
0.0008 11 83 72 28 95%(*F.L) 0.0016-0.0023 
0.002 17 80 48 52 LC95 (ppm) 0.022 
0.005 15 85 27 73 95%(*F.L) 0.0152-0.0397 
0.008 20 88 16 84 Slope 1.51 
Control 2 95 93 7 Tabulated (Chi)
2
 7.8 
     Calculated (Chi)
2
 0.18 
     R-Squared 84.6% 
 
 
 
                 
                                       (A)                                                                                           (B) 
 
Fig.1. The relation between concentrations of spinosad 4.7% (A), diflubenzeroun 2% (B) and mortality percentage of 
Ae.aegypti larvae. 
 
Conc.(ppm) Larval mortality % Statistical parameters Larval
 
stage 
    
0.250 52 95%(*F.L) 0.172-0.276 
0.500 70 LC 95 (ppm) 2 
1.000 86 95%(*F.L) 1.961-6.361 
2.000 96 Slope 1.47 
Tabulated (Chi)
2
 7.8 
Control 0 Calculated  (Chi)
2
 1.24 
R-Squared 80.1% 
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Figure (2) showed morphological abnormalities 
(intermediate stages such as larval siphon, pupal trumpets) 
in developmental stages of Ae. aegypti resulted from 
treatment with diflubenzuron. Several previous studies 
(Bridges et al., 1977 ; Kelada et al., 2006 ;Thangaraj et al., 
1987 and  Baruah and Dus,1996; Bond et al., 2004; Khan 
et al., 2016) are inconsistent with  these findings. Mulla 
(1995) stated that these abnormalities affect the 
developmental stages leading to failure in successful adult 
emergence from pupal exuviae. Additionally, findings of the 
present study are in agreement with findings of several 
studies conducted in different regions of the world (Romi et 
al. 2006;Thavara et al., 2007 and  2009, Seccacini et al.,  
2008; Jiang , Mulla, 2009; Kamal, H., Khater, E. 2010, and 
Suman et al., 2010; Saleh et al., 2013). The slight 
difference in the efficacy range of the compounds among 
these studies could be due to differences in mosquito 
strain, biological response of the tested larvae, compounds 
formulation and experimental conditions. 
 
 
 
                 
                                       (A)                                                                                           (B) 
 
Fig. 2. Abnormalities in the developmental stages of  Ae. aegypti  after treatment with Flubex 2%, (A)  a larval-pupal 
intermediates. (B) Untreated larvae. 
 
 
CONCLUSION 
The study showed that both spinosad and flubex have 
high efficacy against the larval stage and adult emergence 
of Ae.aegypti mosquitoes. 
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